Increasing evidence indicates that RBM39 influences the growth of a range of malignancies, including cholangiocarcinoma, rectum adenocarcinoma, kidney clear cell carcinoma, kidney papillary cell carcinoma, lung SCC, and HNSCCs [127]. Here, RBM39 is linked to rectum adenocarcinoma.